|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-11-5
|
|
pubmed:abstractText |
We assessed the effects of estrogen on vascular dilatory and other homeostatic functions potentially affected by nitric oxide (NO)-potentiating properties in type II diabetic postmenopausal women.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL2,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL,
http://linkedlifedata.com/resource/pubmed/chemical/E-Selectin,
http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, Conjugated (USP),
http://linkedlifedata.com/resource/pubmed/chemical/Hemoglobin A, Glycosylated,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Adhesion Molecule-1,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Plasminogen Activator Inhibitor 1,
http://linkedlifedata.com/resource/pubmed/chemical/Thromboplastin,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Cell Adhesion Molecule-1
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1409-15
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11691516-Brachial Artery,
pubmed-meshheading:11691516-Cardiovascular Diseases,
pubmed-meshheading:11691516-Chemokine CCL2,
pubmed-meshheading:11691516-Cholesterol, HDL,
pubmed-meshheading:11691516-Cholesterol, LDL,
pubmed-meshheading:11691516-Cross-Over Studies,
pubmed-meshheading:11691516-Diabetes Mellitus, Type 2,
pubmed-meshheading:11691516-Double-Blind Method,
pubmed-meshheading:11691516-Drug Synergism,
pubmed-meshheading:11691516-E-Selectin,
pubmed-meshheading:11691516-Estrogens, Conjugated (USP),
pubmed-meshheading:11691516-Female,
pubmed-meshheading:11691516-Fibrinolysis,
pubmed-meshheading:11691516-Hemoglobin A, Glycosylated,
pubmed-meshheading:11691516-Hemostasis,
pubmed-meshheading:11691516-Homeostasis,
pubmed-meshheading:11691516-Humans,
pubmed-meshheading:11691516-Intercellular Adhesion Molecule-1,
pubmed-meshheading:11691516-Matrix Metalloproteinase 9,
pubmed-meshheading:11691516-Middle Aged,
pubmed-meshheading:11691516-Nitric Oxide,
pubmed-meshheading:11691516-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:11691516-Postmenopause,
pubmed-meshheading:11691516-Thromboplastin,
pubmed-meshheading:11691516-Triglycerides,
pubmed-meshheading:11691516-Vascular Cell Adhesion Molecule-1,
pubmed-meshheading:11691516-Vasodilation
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Vascular effects of estrogen in type II diabetic postmenopausal women.
|
|
pubmed:affiliation |
Department of Cardiology, Inchon, South Korea. kwangk@ghil.com
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
